← Insider buys
SRPT

Sarepta Therapeutics, Inc. · Healthcare

Director Hans Lennart Rudolf Wigzell sold $1.6M of Sarepta Therapeutics, Inc.

Sold$1,590,044
$159.00Price
10,000Shares
−42%Stake

What SRPT did after the filing

Prices for SRPT after this filing aren't in yet.

Traded Mon, Aug 10. Filed Tue, Aug 11, 4:00 PM ET, after the close. Not investment advice.